Institutional investors now control 84.58 percent of shares
In the quiet arithmetic of institutional capital, Keysight Technologies has become a gathering point — a company where money managers across the spectrum are choosing to concentrate their conviction. During the first quarter of 2025, major firms including Ameriprise Financial expanded their holdings as Keysight posted earnings that outpaced expectations, with revenue growing more than eleven percent year over year. The stock, trading near $166 with analysts projecting a path toward $200, sits at the intersection of defense, semiconductors, and communications — sectors that the market increasingly treats as essential infrastructure. What emerges is a portrait of institutional consensus forming around a company whose fundamentals appear to be earning the confidence placed in them.
- A broad coalition of institutional investors — from Ameriprise to GAMMA Investing, which tripled its stake — has quietly accumulated over 84 percent of Keysight's outstanding shares, signaling rare and concentrated conviction.
- Keysight's third-quarter earnings beat Wall Street estimates by five cents per share while revenue surpassed forecasts by $30 million, injecting fresh momentum into an already bullish institutional narrative.
- A counterpoint of caution surfaces from within: CFO Neil Dougherty and Senior VP Ingrid Estrada both trimmed their personal holdings in June, a subtle signal that insiders are selectively reducing exposure even as outside money flows in.
- JPMorgan raised its price target to $200 and seven of eight covering analysts rate the stock a buy, with a consensus target of $187.38 implying roughly twelve percent upside from current levels.
- The stock trades at a lofty 52.97 times earnings, meaning the market has already priced in significant future growth — leaving the company's ability to sustain its trajectory as the central question ahead.
Ameriprise Financial made a notable move in the first quarter, expanding its position in Keysight Technologies by nearly sixteen percent to 275,141 shares worth roughly $41 million. But the more striking story is the breadth of institutional agreement surrounding that decision. GAMMA Investing more than tripled its stake, Praxis Investment Management grew its holdings by nearly half, and several other major firms added meaningfully to their positions. Together, institutional investors now hold over 84 percent of Keysight's outstanding shares — a concentration that speaks to something beyond routine portfolio rebalancing.
The timing reflects real operational momentum. Keysight's third-quarter earnings of $1.72 per share beat analyst expectations, and revenue of $1.35 billion came in above forecasts while growing more than eleven percent from the prior year. Return on equity reached nearly twenty percent, and management guided full-year 2025 earnings at $7.09 per share. The balance sheet is clean, with a current ratio above three and modest debt relative to equity.
Not everyone is leaning in. CFO Neil Dougherty sold over twelve thousand shares in late June, trimming his stake by nearly ten percent, and Senior Vice President Ingrid Estrada similarly reduced her position. Insiders collectively own less than one percent of the company — a reminder that those closest to the business are taking a more measured view even as outside capital accumulates.
The stock closed near $166, comfortably within its 52-week range and carrying a market cap of $28.62 billion. Wall Street's posture is decidedly optimistic: JPMorgan raised its price target to $200, Morgan Stanley lifted its target to $180, and the analyst consensus sits at a $187.38 target with a moderate buy rating. Keysight's two divisions — serving aerospace and networking on one side, and automotive, energy, and semiconductors on the other — give it exposure to sectors the market currently views as durable growth engines. For now, the institutional world appears to be betting that the runway ahead justifies the premium.
Ameriprise Financial has deepened its bet on Keysight Technologies, expanding its stake in the electronic design and test company by nearly 16 percent during the first quarter. The financial services firm now holds 275,141 shares worth roughly $41 million, having added 37,678 shares to its portfolio in recent months. This move signals confidence from one of the nation's largest wealth management firms, but Ameriprise is far from alone in its conviction.
Across the institutional investment landscape, a broad coalition of money managers has been quietly accumulating Keysight stock. Praxis Investment Management nearly doubled its position, growing holdings by 45.8 percent. GAMMA Investing LLC more than tripled its stake, jumping 142.8 percent. Allspring Global Investments, Foyston Gordon & Payne, and Wealth Enhancement Advisory Services all expanded their positions as well, with increases ranging from 3.2 to 19.8 percent. Collectively, institutional investors now control 84.58 percent of Keysight's outstanding shares—a concentration that reflects deep institutional confidence in the company's direction.
The timing of these purchases aligns with Keysight's recent operational momentum. In August, the company reported third-quarter earnings of $1.72 per share, beating analyst expectations by five cents. Revenue climbed to $1.35 billion, up 11.1 percent from the same quarter a year prior and exceeding Wall Street's forecast of $1.32 billion. The company's net profit margin sits at 10.36 percent, and return on equity reached 19.53 percent—metrics that suggest operational efficiency and shareholder-friendly capital deployment. Management has guided fourth-quarter earnings between $1.79 and $1.85 per share, with full-year 2025 guidance at $7.09 per share.
Insiders have taken a different tack. In late June, Chief Financial Officer Neil Dougherty sold 12,215 shares at an average price of $164.60, reducing his stake by 9.58 percent but still leaving him with 115,228 shares valued at roughly $19 million. Senior Vice President Ingrid Estrada similarly trimmed her position, selling 10,000 shares on June 20th at $158.97 per share. These transactions, while modest in scale, suggest executives are taking some chips off the table even as the broader institutional world accumulates stock. Insiders collectively own just 0.61 percent of the company.
The stock itself has been climbing. Keysight closed Friday at $166.31, near the middle of its 52-week range of $121.43 to $186.20. The company carries a market capitalization of $28.62 billion and trades at a price-to-earnings multiple of 52.97 times, reflecting investor expectations for continued growth. The balance sheet appears solid, with a current ratio of 3.59 and a debt-to-equity ratio of 0.45.
Wall Street has turned decidedly bullish. JPMorgan Chase raised its price target to $200 in mid-July, assigning an overweight rating. Morgan Stanley lifted its target to $180 in May. Barclays and Bank of America both maintain overweight ratings, though Barclays trimmed its target slightly to $195 following the earnings report. Seven analysts rate the stock as a buy; one rates it hold. The consensus price target stands at $187.38, suggesting roughly 12 percent upside from current levels.
Keysight operates across two main divisions: a Communications Solutions Group serving the networking and aerospace sectors, and an Electronic Industrial Solutions Group serving automotive, energy, and semiconductor customers. The company's reach spans the Americas, Europe, and Asia Pacific. For investors watching the technology and defense sectors, Keysight's combination of institutional accumulation, solid earnings growth, and analyst enthusiasm suggests the market sees meaningful runway ahead.
Notable Quotes
Keysight reported earnings of $1.72 per share for the quarter, topping analyst consensus estimates of $1.67— Company earnings report, August 19, 2025
The Hearth Conversation Another angle on the story
Why are so many institutional investors buying Keysight at the same time? Is this coordinated?
It's not coordinated in any formal sense, but it's not random either. When a company starts beating earnings estimates and growing revenue double digits, money managers notice. They're all reading the same earnings reports, the same analyst notes. The momentum becomes self-reinforcing.
But the insiders are selling. Doesn't that contradict the institutional buying?
Not necessarily. Insiders sell for all kinds of reasons—diversification, tax planning, life events. A CFO selling 9 percent of his stake isn't a red flag. If he were dumping everything, that would be different. He still owns over 100,000 shares.
The stock trades at a P/E of 53. That seems expensive.
It does on its face. But the company is growing revenue at 11 percent and beating estimates. If growth continues, that multiple compresses. Investors are betting on the trajectory, not the current valuation.
What's the actual business here? Why does it matter?
Keysight makes the tools that engineers use to design and test electronic equipment. Semiconductors, communications networks, defense systems, automotive electronics. It's infrastructure for the entire tech and defense ecosystem. When those sectors are investing, Keysight benefits.
So this is a bet on AI and defense spending?
Partly. The semiconductor and communications segments would benefit from AI buildout. The aerospace and defense exposure is real too. But it's also just a well-run company with pricing power and recurring revenue streams.
What could go wrong?
Recession would hurt capital spending. A slowdown in semiconductor demand would ripple through. Valuation compression if growth disappoints. But right now, the company is executing, and the market is rewarding it.